iiinova — where your digital self keeps evolving

AVAC @avac.org · 30/09/2026

From 1 antibody to 3: the #bNAb field is moving toward combination approaches designed to provide broader, long-acting protection against #HIV. Huub Gelderblom of #HVTN takes us through the pipeline. We’re live for the next 40 minutes, join us: avac.org/event/whats-...

000

AVAC @avac.org · 29/09/2026

ICYMI, happening tomorrow! What’s next for broadly neutralizing antibodies or #bNAbs for #HIV prevention? Join Huub Gelderblom, Sharana Mahomed, Matthew Rose, Pervin Anklesaria & John Mascola for the latest! Register: avac.org/event/whats-... #HIVprevention #HIVcure

011

AVAC @avac.org · 25/09/2026

Big issue of #GlobalHealthWatch this week tracking pushback against political influence over NIH research, proposed #NIAID restructuring, the path to generic lenacapavir for PrEP and the Accra Reset’s vision for a new #globalhealth architecture. avac.org/blog/global-...

000

AVAC @avac.org · 24/09/2026

Our latest #STIWatch newsletter looks at how advocates are turning evidence into action, from advancing country-led #STI priorities and strengthening syndromic management to tracking new data, guidance and perspectives shaping STI prevention, diagnosis and care. 🔗 www.stiwatch.org/resources/st...

000

AVAC @avac.org · 23/09/2026

“The future of AI in HIV should be shaped with communities, not simply built from data about them.” — Solange Baptiste, @itpc.bsky.social The latest AI + HIV newsletter explores #AIDS2026 rx, emerging tools, governance, equity and accountability. 🔗 Read the issue: avac.org/ai-hiv-issue2/

012

AVAC @avac.org · 23/09/2026

"Do vaginas demand perfection" Jenell Stewart just asked on #TheChoiceAgenda webinar as she shared data from Dr. Marrazzo + colleagues, which challenge assumptions about the need for perfect oral #PrEP daily adherence among cisgender♀️. Join: avac.org/event/evolvi...

000

AVAC @avac.org · 22/09/2026

Happening Tomorrow 🔽 🔗 Register: avac.org/event/evolvi... #PrEP #HIVprevention #HIV

000

AVAC @avac.org · 18/09/2026

This week's #GlobalHealthWatch covers new pathways for #lenacapavir access, push back on the proposed #NIAID reorganization, new Global Fund data, which shows #HIV prevention is taking a hit & scientists file a class action lawsuit challenge NIH grant screening. 🔗 avac.org/blog/global-...

010

AVAC @avac.org · 17/09/2026

Join us September 30 for a global webinar to hear the latest updates on the #bNAb pipeline and to discuss what the future holds. 🔗 avac.org/event/whats-... #HIV #HIVprevention #CAPRISA

065

AVAC @avac.org · 14/09/2026

AVAC's Clinical Trial Design Academy shows what’s possible when advocates have the scientific know how to influence research—from influencing trial design to bringing community priorities into research decisions. Explore this story + more in the new #AVACImpactReport. ⬇️ avac.org/blog/clinica...

011

AVAC @avac.org · 11/09/2026

New issue of #GlobalHealthWatch: The systems that sustain #globalhealth are shifting—from how biomedical research is funded and organized to the institutions behind #vaccine development and US foreign assistance. We track the changes, what’s at stake & what to watch next. avac.org/blog/global-...

001

AVAC @avac.org · 10/09/2026

Our latest #ImpactReport looks at how Good Participatory Practices or #GPP strengthens research—from trial design to communications to implementation—and why meaningful engagement matters. 🔗 avac.org/blog/the-imp... #HIV #HIVprevention

000

AVAC @avac.org · 27/08/2026

Our new issue of #PxWire cover's Merck/MSD’s decision to license #alimatravir to 7 generic manufacturers before efficacy results, setting a benchmark for access. But gaps remain, including the exclusion of Brazil & other countries from the license. Read more: avac.org/resource/rep... #PrEP #HIV

021

AVAC @avac.org · 24/08/2026

NEW from #STIWatch Perspectives: Leandro Mena reflects on the promise of #DoxyPEP & what it'll take to move from evidence to equitable impact, including community leadership, trusted services, stronger diagnostics & responsible AMR surveillance. 🔗 www.stiwatch.org/doxypep-beyo... #STIs #AIDS2026

001

AVAC @avac.org · 21/08/2026

This week in #GlobalHealthWatch: #NIH reopens research funding to South Africa; the DRC’s escalating #Ebola outbreak shows impact of weakened global outbreak-response systems; leadership shifts at #WHO and #FDA. Read the latest from AVAC: avac.org/blog/global-... #HIV #HIVprevention #globalhealth

011

AVAC @avac.org · 17/08/2026

Meet AVAC’s 2026 #HIV Cure Academy Alumni Fellows! Five alumni are putting what they gained thru the Academies into action—strengthening community engagement, informing policy & advancing #HIVcure research. Learn more about the projects fellows are leading: avac.org/blog/announc...

011

AVAC @avac.org · 14/08/2026

New #GlobalHealthWatch is out! It covers the US Admins $2B shift to faith-based #globalhealth funding, growing congressional oversight of #PEPFAR & foreign aid, new restrictions on #NIH policy research & big changes to US childhood vaccine recommendations. Read: avac.org/blog/global-... #HIV

020

AVAC @avac.org · 13/08/2026

🧵"Researchers bring scientific expertise, but communities bring lived experiences, they bring contextual understanding, political understanding and trust. Neither can replace the other." — Grace Kumwenda on todays #ChoiceAgenda webinar, avac.org/event/persis...

100

AVAC @avac.org · 13/08/2026

Happening Now 🔻 Join Annesa Flentje, Brian Mustanski, Grace Kumwenda, Luciana Kamel and Tabea Hässler for an important conversation on sustaining health equity research in today's rapidly changing landscape. 🔗 avac-org.zoom.us/meeting/regi...

000

AVAC @avac.org · 12/08/2026

A great post- #AIDS2026 perspective on the future from @miamalan.bsky.social. bhekisisa.org/opinion/2026... #HIV #PrEP

034

AVAC @avac.org · 07/08/2026

#GlobalHealthWatch this week: Senate votes to hold #Fauci in contempt as Steven Quay emerges as the leading candidate to head #NIAID, lawmakers block the White House's proposal to politicize federal rx grants, & we unpack the biggest takeaways from #AIDS2026. 🔗 avac.org/blog/global-...

001

AVAC @avac.org · 07/08/2026

Following the AIDS 2026 conference in Rio de Janeiro, our team compiled a list of AVAC’s top 10 takeaways. These topics sparked discussions and ideas among our team and AVAC’s larger partner network, and will carry our work well into the future. Read more at buff.ly/8ebJ704 and watch here:

000

AVAC @avac.org · 06/08/2026

Stop this persecution of Dr. Fauci. Read our press release here: buff.ly/CMfrqOZ

020

AVAC @avac.org · 04/08/2026

below): ICYMI, this week's #GlobalHealthWatch covers key takeaways from #AIDS2026, #Fauci's Senate hearing & growing attacks on #science, new US restrictions on gain-of-function research & @Gavi finally receives funding, buff.ly/NTx4XzD

022

AVAC @avac.org · 30/07/2026

"Communities need to design. We may not understand all the #science, but trust me, we are brilliant when it comes to designing research around what we really need." A powerful reminder from our Grace Kumwenda & panelists at the #AIDS2026 session "From community to innovation to scale." #HIV #PrEP

012

AVAC @avac.org · 30/07/2026

As the #AIDS2026 conference enters its 2nd half, one message has emerged above all others: the barriers to ending #HIV are no longer primarily scientific; they are political. Read our summary of conference highlights so far, avac.org/blog/science...

022

AVAC @avac.org · 29/07/2026

“The evidence was always there - it still is. Now the question is if these lives are worth the risk and political will it takes to save them. That is not a scientific question, it is a moral one” - Raphael Landovitz at today's #AIDS2026 plenary #rethinkrebuildrise

001

AVAC @avac.org · 28/07/2026

🧵 "...alimatravir for $3 a yr could be the cheapest #HIVprevention drug the world has ever seen... But it needs to be $3 everywhere, not just some places." - Sam Cross in the #AIDS2026 Economics of Impact session.

152

AVAC @avac.org · 28/07/2026

"We need a community governance layer built into the AI ecosystem - one that ensures communities help shape priorities & hold systems accountable” - @itpc.bsky.social's Solange Baptiste @ “AI & HIV: Who owns the future of public health". See our #AIDS2026 #AIHIV roadmap, avac.org/wp-content/u...

012

AVAC @avac.org · 28/07/2026

"PrEP is about choice and our different lifestyles." — Josephine Aseme, the 1st person to receive #lenacapavir for PrEP in Nigeria, speaking at Real Talk, Real Access: KP Community Demands for the Next Wave of PrEP. Communities are leading the conversation on what's next. #AIDS2026 #PrEP

012

AVAC @avac.org · 28/07/2026

Follow along with whats happening at the @iasociety.bsky.social's #AIDS2026 conference in Rio. 📖 AVAC's first dispatch, avac.org/blog/innovat... “Innovation without access is injustice.” That msg, delivered during Mon.'s opening ceremony captured the defining theme emerging in Rio.

084

AVAC @avac.org · 28/07/2026

Lots happening at the #AIDS2026 #HIVprevention and #cure networking zone (booth 135) today! Here's the lineup (Brazil time): 💠 Let's Gossip About PrEP: 10:30am 💠 Real Talk, Real Access: 12:15pm 💠 PEP Rally: 16:00pm Full schedule at: avac.org/aids2026-nz/

021

AVAC @avac.org · 27/07/2026

#HIVunwrapped took center stage at the opening ceremony of #AIDS2026! Where fashion meets #science — a powerful look at how #hiv researchers and fashion designers are teaming up to bring information on HIV to new audiences, vimeo.com/1140217977/4...

053

AVAC @avac.org · 27/07/2026

"Yet @ the very moment science is opening doors, many of those doors are closed... Innovation without access becomes privilege. Science commitment cannot save lives, & a breakthrough that reaches only a few is not a breakthrough for humanity." - Alberto Pereira Da Silva Jr. at the #AIDS2026 opening

022

AVAC @avac.org · 27/07/2026

The new @unaids.org "United to End AIDS" just released at #AIDS2026 makes clear that progress is at risk, www.unaids.org/en/resources... "This is an alarm bell... We have to change how we do what we do and how we fund what we do if we want to succeed."

020

AVAC @avac.org · 27/07/2026

And be sure to visit the AVAC crew at booth 135 for all things #HIVcure and #HIVprevention, including the latest on #lenacapavir and #alimatravir. See our schedule, avac.org/aids2026-nz/

010

AVAC @avac.org · 27/07/2026

"Science creates the possibility, collaboration creates the impact, but communities create the future." - Well said, Max Lataillade @gatesfoundation.bsky.social #AIDS2026 #HIVprevention #PrEP

030

AVAC @avac.org · 27/07/2026

🧵 "I think it's safe to say, as we sit here in Rio now, 16 yrs since we first learned that #PrEP was safe & effective as a daily oral tablet, we have successfully squandered our opportunities." #AIDS2026 #HIVprevention

112

AVAC @avac.org · 27/07/2026

Happening Now! Still time to join AVAC's satellite session at #AIDS2026. programme.aids2026.org/Programme/Se...

011

AVAC @avac.org · 26/07/2026

"I didn't know clinical trial data could become the building blocks for national policies & [real-life access]," said Adaobi Lisa Olisa. The Clinical Trial Design Academy changed that—and "now I'm able to engage and contribute meaningfully to the research." #AIDS2026 avac.org/project/the-...

000

AVAC @avac.org · 26/07/2026

We're at the #AIDS2026 #HIVprevention precon & just heard from Merck's Rebeca Plank, who shared updates on #MK-8527 #alimatravir, the monthly oral #PrEP candidate. Here are a few highlights. Visit AVAC for all things MK-8527, www.prepwatch.org/products/mk-... #PrEP #HIVPrevention

022

AVAC @avac.org · 25/07/2026

See AVAC's roadmap for all things #HIVprevention at #AIDS2026.

011

AVAC @avac.org · 24/07/2026

Lots of conversation about #PrEP access to be expected in Rio at @iasociety.bsky.social #AIDS2026 this week. See AVAC's statement on the Merck/MSD oral PrEP access news, avac.org/blog/monthly... #HIV #HIVprevention #alimatravir

002

AVAC @avac.org · 24/07/2026

"Granting licensing agreements to generic manufacturers while clinical trials are still enrolling, before it is known if the product is effective, should significantly reduce the time to market for the product." See AVAC's statement on Merck's #PrEP oral pill news, avac.org/press-releas... #HIV

000

AVAC @avac.org · 19/07/2026

Everything #HIVprevention in one place. Check out AVAC's HIV Prevention Roadmap at #AIDS2026—your guide to the week's top prevention sessions, advocacy events, resources and more. buff.ly/cSm4vva

012

AVAC @avac.org · 17/07/2026

New issue of #GlobalHealthWatch is out! avac.org/blog/global-...

000

AVAC @avac.org · 17/07/2026

Attending @iasociety.bsky.social #AIDS2026 in Rio? Join us and partners for four days of discussion, networking, info sharing and more in the Research & Advocacy Networking Zone. See the full program: avac.org/aids2026-nz/ @aphaza.bsky.social

011

AVAC @avac.org · 17/07/2026

"The #SaveHIVFunding campaign has collectively beat back $3.5 billion in US funding cuts." — Jeremiah Johnson at today's @prep4allnow.bsky.social rally. Advocacy works. But the fight to protect #HIV research, prevention & treatment isn't over. #SaveHIVFunding #AIDS2026

000

AVAC @avac.org · 16/07/2026

During its 8 yrs, #CASPR built an Africa-led movement that connected communities, researchers, policymakers, journalists & funders to transform #HIV prevention advocacy. Read more about the legacy of CASPR, avac.org/blog/legacy-... #HIVprevention #communityengagement

000

AVAC @avac.org · 15/07/2026

Attending the @iasociety.bsky.social #AIDS2026 conference in Rio? See AVAC's Guide to AIDS 2026, including roadmaps on AI & #HIV, #HIVprevention, the latest infographics and resource hubs on #lenacapavir, #MK-8527 and the prevention pipeline. Access our guide: avac.org/event/aids-2...

011